Inve India ▾
NONOCIL

NOCIL Q2 FY25 results (Jul–Sep 2024) and concall

Chemicals · Concall AI · Call held 29 Oct 2024

NOCIL delivered a mixed performance in Q2 FY25, characterized by robust year-on-year volume growth but significant margin pressure. While domestic and export demand remains healthy, aggressive pricing and product dumping from competitors in China, Korea, and the EU compressed profitability. A sequential dip in sales volume was attributed to temporary logistical issues. The company's reported profit was inflated by a one-time tax credit, masking weaker underlying operational performance.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

₹ Cr · quarterly
Line itemQ2 FY25
Revenue363
EBITDA38
Net profit42
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.